UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rapid enhancement of two-step wiring plasticity by estrogen and NMDA receptor activity

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (38), p.14650-14655

2008

Volltextzugriff (PDF)

Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones

The Journal of physiology, 2005-05, Vol.564 (3), p.907-921

2005

Volltextzugriff (PDF)

Small-Molecule Intramimics of Formin Autoinhibition: A New Strategy to Target the Cytoskeletal Remodeling Machinery in Cancer Cells

Cancer research (Chicago, Ill.), 2013-11, Vol.73 (22), p.6793-6803

2013

Volltextzugriff (PDF)

Isolation, Amino Acid Sequence and Biological Activities of Novel Long-Chain Polyamine-Associated Peptide Toxins from the Sponge Axinyssa aculeata

Chembiochem : a European journal of chemical biology, 2011-09, Vol.12 (14), p.2191-2200

2011

Volltextzugriff (PDF)

Full Domain Closure of the Ligand-binding Core of the Ionotropic Glutamate Receptor iGluR5 Induced by the High Affinity Agonist Dysiherbaine and the Functional Antagonist 8,9-Dideoxyneodysiherbaine

The Journal of biological chemistry, 2009-05, Vol.284 (21), p.14219-14229

2009

Volltextzugriff (PDF)

Total Synthesis and Biological Evaluation of Neodysiherbaine A and Analogues

Journal of organic chemistry, 2006-07, Vol.71 (14), p.5208-5220

2006

Volltextzugriff (PDF)

Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors

The Journal of pharmacology and experimental therapeutics, 2008-02, Vol.324 (2), p.484-496

2008

Volltextzugriff (PDF)

Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine

Neuropharmacology, 2010-03, Vol.58 (3), p.640-649

2010

Volltextzugriff (PDF)

Cover Picture: Isolation, Amino Acid Sequence and Biological Activities of Novel Long-Chain Polyamine-Associated Peptide Toxins from the Sponge Axinyssa aculeata (ChemBioChem 14/2011)

Chembiochem : a European journal of chemical biology, 2011-09, Vol.12 (14), p.2101-2101

2011

Volltextzugriff (PDF)

Mechanisms of membrane estrogen receptor-α-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line

American journal of physiology: endocrinology and metabolism, 2005-02, Vol.51 (2), p.E388-E397

2005

Volltextzugriff (PDF)

Abstract 2130: Small molecule activation of diaphanous-related formins as a novel anti-cancer strategy

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2130-2130

2013

Volltextzugriff (PDF)

Detailed Safety Analysis of Venetoclax Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Blood, 2016-12, Vol.128 (22), p.2033-2033

2016

Volltextzugriff (PDF)

Safety and Preliminary Efficacy from the Expansion Cohort of a Phase 1/2 Study of Venetoclax Plus Daratumumab and Dexamethasone Vs Daratumumab Plus Bortezomib and Dexamethasone in Patients with t(11;14) Relapsed/Refractory Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.817-817

2021

Volltextzugriff (PDF)

Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line

American journal of physiology: endocrinology and metabolism, 2005-02, Vol.288 (2), p.E388-E397

2005

Volltextzugriff (PDF)

Impact of Number of Prior Therapies and Bulk of Disease on Outcomes with Venetoclax (VEN) Monotherapy for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Blood, 2017-12, Vol.130, p.4329-4329

2017

Volltextzugriff (PDF)

Mechanisms of membrane estrogen receptor-α-mediated rapid stimulation of Ca 2+ levels and prolactin release in a pituitary cell line

American journal of physiology: endocrinology and metabolism, 2005-02, Vol.288 (2), p.E388-E397

2005

Volltextzugriff (PDF)

Mechanisms of membrane estrogen receptor-{alpha}-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line

American journal of physiology: endocrinology and metabolism, 2005-02, Vol.288 (2), p.E388

2005

Volltextzugriff (PDF)

Exposure-Response Analysis Supports a Lower Dose of Venetoclax in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma Patients When Combined with Daratumumab and Dexamethasone

Blood, 2022-11, Vol.140 (Supplement 1), p.10122-10123

2022

Volltextzugriff (PDF)

An Updated Safety and Efficacy Analysis of Venetoclax Plus Daratumumab and Dexamethasone in an Expansion Cohort of a Phase 1/2 Study of Patients with t(11;14) Relapsed/Refractory Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.7261-7263

2022

Volltextzugriff (PDF)

Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies

Future oncology (London, England), 2018-09, Vol.14 (21), p.2115-2129

2018

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

Rapid enhancement of two-step wiring plasticity by estrogen and NMDA receptor activity

Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones

Small-Molecule Intramimics of Formin Autoinhibition: A New Strategy to Target the Cytoskeletal Remodeling Machinery in Cancer Cells

Isolation, Amino Acid Sequence and Biological Activities of Novel Long-Chain Polyamine-Associated Peptide Toxins from the Sponge Axinyssa aculeata

Full Domain Closure of the Ligand-binding Core of the Ionotropic Glutamate Receptor iGluR5 Induced by the High Affinity Agonist Dysiherbaine and the Functional Antagonist 8,9-Dideoxyneodysiherbaine

Total Synthesis and Biological Evaluation of Neodysiherbaine A and Analogues

Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors

Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine

Cover Picture: Isolation, Amino Acid Sequence and Biological Activities of Novel Long-Chain Polyamine-Associated Peptide Toxins from the Sponge Axinyssa aculeata (ChemBioChem 14/2011)

Mechanisms of membrane estrogen receptor-α-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line

Abstract 2130: Small molecule activation of diaphanous-related formins as a novel anti-cancer strategy

Detailed Safety Analysis of Venetoclax Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Safety and Preliminary Efficacy from the Expansion Cohort of a Phase 1/2 Study of Venetoclax Plus Daratumumab and Dexamethasone Vs Daratumumab Plus Bortezomib and Dexamethasone in Patients with t(11;14) Relapsed/Refractory Multiple Myeloma

Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line

Impact of Number of Prior Therapies and Bulk of Disease on Outcomes with Venetoclax (VEN) Monotherapy for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Mechanisms of membrane estrogen receptor-α-mediated rapid stimulation of Ca 2+ levels and prolactin release in a pituitary cell line

Mechanisms of membrane estrogen receptor-{alpha}-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line

Exposure-Response Analysis Supports a Lower Dose of Venetoclax in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma Patients When Combined with Daratumumab and Dexamethasone

An Updated Safety and Efficacy Analysis of Venetoclax Plus Daratumumab and Dexamethasone in an Expansion Cohort of a Phase 1/2 Study of Patients with t(11;14) Relapsed/Refractory Multiple Myeloma

Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies

Suchergebnisse filtern